{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:34:26Z","timestamp":1792625666192,"version":"4.5.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Our objective was to investigate the predictive and diagnostic accuracy of the angiogenic proteins sFlt-1 (soluble fms\u2013like tyrosine kinase-1) and PlGF (placental growth factor) for preterm preeclampsia and explore the relationship between renal function and these proteins.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We completed a blinded, prospective, longitudinal, observational study of patients with chronic kidney disease followed at a tertiary center (2018\u20132023). Serum samples were obtained at 3 time points along gestation (planned sampling): 12\u201316, 18\u201322, and 28\u201332 weeks. In addition, samples were obtained whenever preeclampsia was suspected (indicated sampling). sFlt-1 and PlGF levels remained concealed until the study ended. The primary outcome was preterm preeclampsia. The planned and indicated samples were used to estimate the predictive and diagnostic accuracy of the angiogenic proteins, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Of the 97 participants, 21 (21.6%) experienced preterm preeclampsia. In asymptomatic patients with chronic kidney disease, the angiogenic proteins were predictive of preterm preeclampsia only when sampled in the third trimester, in which case the sFlt-1\/PlGF ratio (false positive rate of 37% for a detection rate of 80%) was more predictive than either sFlt-1 or PlGF in isolation. In patients with suspected preeclampsia, the diagnostic accuracy of the sFlt-1\/PlGF ratio (false positive rate of 26% for a detection rate of 80%) was higher than that of sFlt-1 and PlGF in isolation. Diminished renal function was associated with increased levels of PlGF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>sFlt-1 and PlGF can effectively predict and improve the diagnostic accuracy for preterm preeclampsia among patients with chronic kidney disease. The optimal sFlt-1\/PlGF ratio cutoff to rule out preeclampsia may need to be lower in patients with impaired renal function.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/hypertensionaha.124.23411","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T09:00:34Z","timestamp":1724144434000},"page":"2251-2262","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Predictive and Diagnostic Value of the Angiogenic Proteins in Patients With Chronic Kidney Disease"],"prefix":"10.1161","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2704-1385","authenticated-orcid":true,"given":"Nir","family":"Melamed","sequence":"first","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, Temerty Faculty of Medicine (N.M., I.A.-C., D.H.), University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Kingdom","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai Hospital, Temerty Faculty of Medicine (J.C.K.), University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5291-5291","authenticated-orcid":true,"given":"Lei","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre (L.F., P.M.Y.), University of Toronto, Ontario, Canada."},{"name":"Department of Laboratory Medicine and Pathobiology (L.F., P.M.Y.), University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Yip","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre (L.F., P.M.Y.), University of Toronto, Ontario, Canada."},{"name":"Department of Laboratory Medicine and Pathobiology (L.F., P.M.Y.), University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6862-570X","authenticated-orcid":true,"given":"Isabel","family":"Arruda-Caycho","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, Temerty Faculty of Medicine (N.M., I.A.-C., D.H.), University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dini","family":"Hui","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, Temerty Faculty of Medicine (N.M., I.A.-C., D.H.), University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-4292","authenticated-orcid":true,"given":"Michelle A.","family":"Hladunewich","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Obstetric Medicine, Department of Medicine, Sunnybrook Health Sciences Centre, Temerty Faculty of Medicine (M.A.H.), University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2015.12.050"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39406.652986.BE"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000119"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09250914"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2109523"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2019.03.005"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004149"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-022-06864-y"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1560-2"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2020.02.004"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17189"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1429"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005532"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414838"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)33212-4"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12195"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200161"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.10.044"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.26032"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.1.77"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232416059"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.867929"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.339"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-015-0487-4"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009010061"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020111579"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2015.10.012"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000339935"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.348"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/127083"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2020.09.007"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2021.02.010"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-022-01299-9"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.2.e35"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000437382.03963.88"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13499"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13522"},{"key":"e_1_3_3_40_2","first-page":"1","article-title":"Placental growth factor (PlGF)- based biomarker testing to help diagnose pre-eclampsia in people with suspected pre-eclampsia: a health technology assessment.","volume":"23","author":"Ontario H","year":"2023","unstructured":"Ontario H. Placental growth factor (PlGF)- based biomarker testing to help diagnose pre-eclampsia in people with suspected pre-eclampsia: a health technology assessment. Ont Health Technol Assess Ser. 2023;23:1\u2013146.","journal-title":"Ont Health Technol Assess Ser"},{"key":"e_1_3_3_41_2","unstructured":"Findlay S Girling J Haslam S Myers J Sharp A Sheehan E Simpson N Vatish M. NICE guidelines DG23: PlGF-based testing to help diagnose suspected pre-eclampsia. 2016. www.nice.org.uk\/guidance\/dg23"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2301"},{"key":"e_1_3_3_43_2","unstructured":"Findlay S Girling J Haslam S Myers J Sharp A Sheehan E Simpson N Vatish M. National Institute for Health and Care Excellence (NICE) diagnostics guidance 49: PLGF-based testing to help diagnose suspected preterm pre-eclampsia. 2022. https:\/\/www.nice.org.uk\/guidance\/DG49"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2021.09.008"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2022.03.002"},{"key":"e_1_3_3_46_2","unstructured":"U.S. Food and Drug Administration. FDA roundup May 19 2023. 2023. Accessed April 1 2024. https:\/\/fda.gov\/news-events\/press-announcements\/fda-roundup-may-19-2023"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13763"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13360"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.03.032"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1159\/000341264"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17096"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.21568"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17684"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.08.034"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft256"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.03.032"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00820.x"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.124.23411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T20:21:14Z","timestamp":1750796474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.124.23411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.124.23411"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.124.23411","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}